Funds used for sales, marketing, distribution, research, development
By Devika Patel
Knoxville, Tenn., Feb. 13 - Amedica Corp. said it priced its $20.13 million initial public sale of stock with a $3.02 million greenshoe. The deal was announced Nov. 8.
The company priced 3.5 million common shares at $5.75 per share.
Settlement is expected Feb. 19.
JMP Securities LLC is the bookrunner.
Proceeds will be used for sales, marketing, distribution, research and development, commercialization, capital needs and other general corporate purposes.
The commercial biomaterial company is based in Salt Lake City. The company expects its shares will trade on the Nasdaq under the symbol "AMDA."
| Issuer: | Amedica Corp.
|
| Issue: | Common stock
|
| Amount: | $20,125,000
|
| Greenshoe: | $3,018,750
|
| Shares: | 3.5 million
|
| Price: | $5.75
|
| Warrants: | No
|
| Bookrunner: | JMP Securities LLC
|
| Co-manager: | Needham & Co., LLC
|
| Announcement date: | Nov. 8
|
| Pricing date: | Feb. 13
|
| Settlement date: | Feb. 19
|
| Stock symbol: | Nasdaq: AMDA
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
